<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">AJMB</journal-id>
			<journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
			<issn pub-type="ppub">2008-2835</issn>
			<issn pub-type="epub">2008-4625</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">AJMB-2-87</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Conjugation of R-Phycoerythrin to a Polyclonal Antibody and F (ab&#x0027;)2 Fragment of a Polyclonal Antibody by Two Different Methods</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Mahmoudian</surname>
						<given-names>Jafar</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Jeddi-Tehrani</surname>
						<given-names>Mahmood</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Rabbani</surname>
						<given-names>Hodjattallah</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Mahmoudi</surname>
						<given-names>Ahmad Reza</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Akhondi</surname>
						<given-names>Mohammad Mehdi</given-names>
					</name>
					<xref ref-type="aff" rid="AF0003">3</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Zarnani</surname>
						<given-names>Amir Hassan</given-names>
					</name>
					<xref ref-type="aff" rid="AF0004">4</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Goli</surname>
						<given-names>Leila Balaei</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Babaei</surname>
						<given-names>Mahdokht</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Ghods</surname>
						<given-names>Roya</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
					<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
				</contrib>
			</contrib-group>
			<aff id="AF0001">
				<label>1</label>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<aff id="AF0002">
				<label>2</label>Immune and Gene Therapy Lab, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden</aff>
			<aff id="AF0003">
				<label>3</label>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<aff id="AF0004">
				<label>4</label>Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<author-notes>
				<corresp id="cor1">
					<label>&#x002A;</label>
					<bold>Corresponding author:</bold> Roya Ghods, M.Sc., Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. P.O. Box: 19615-1177. <bold>Tel:</bold> +982122432020. <bold>Fax:</bold> +0982122432021. <bold>E-mail:</bold> <email xlink:href="ghods@avicenna.ac.ir">ghods@avicenna.ac.ir</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="ppub">
				<season>April-June</season>
				<year>2010</year>
			</pub-date>
			<volume>2</volume>
			<issue>2</issue>
			<fpage>87</fpage>
			<lpage>91</lpage>
			<history>
				<date date-type="received">
					<day>15</day>
					<month>05</month>
					<year>2010</year>
				</date>
				<date date-type="accepted">
					<day>19</day>
					<month>06</month>
					<year>2010</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2010 Avicenna Research Institute</copyright-statement>
				<copyright-year>2010</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
			<abstract>
					<p>R-Phycoerythrin (R-PE), a fluorescent protein from phycobiliprotein family, is isolated from red algae. Conjugation of antibodies to R-PE facilitates multiple fluorescent staining methods. In the present study polyclonal antibodies and polyclonal F(ab&#x0027;)2 fragment antibodies were conjugated to R-PE by two different methods. The efficiency of the methods was evaluated using Immunocytochemistry (ICC) and Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE). In the first conjugation method, PE was attached to SMCC linker followed by conjugation of antibody to PE-SMCC. In the second method, SH groups were added onto R-PE molecule, while the antibody was attached to SPDP linker. Then, the antibody-SPDP molecule was conjugated to R-PE. Our results showed that the two conjugation methods did not have any abrogative effects on the antibody binding activity.</p>
			</abstract>
			<kwd-group>
				<kwd>Antibody</kwd>
				<kwd>Conjugation</kwd>
				<kwd>Immunocytochemistry</kwd>
				<kwd>Phycoerythrin</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec id="S0001">
			<title>Introduction</title>
			<p>R-Phycoerythrin (R-PE) is one of the most commonly-used fluorescent dyes for fluorescent staining and other immunoassays. R-PE is a large protein (approximately 240 <italic>kDa</italic>) containing 25 fluors (<xref ref-type="bibr" rid="CIT0001">1</xref>). R-PE has three types of subunits: alpha (&#x223C;20,000 daltons), beta (&#x223C;20,000 daltons) and gamma (&#x223C;30,000 daltons) and its subunit structure [(alpha-beta) 6 gamma] has been determined (<xref ref-type="bibr" rid="CIT0002">2</xref>). Typically, only one PE molecule is conjugated to one antibody molecule (<xref ref-type="bibr" rid="CIT0003">3</xref>).</p>
			<p>Nonetheless, by virtue of its huge absorption coefficient and almost perfect quantum efficiency it is one of the brightest dyes used today. It emits at about 570 <italic>nm</italic>, and is excited by an argon laser tuned to 488 <italic>nm</italic>; however, much more sensitive detection is obtained with a laser tuned to 533 <italic>nm</italic> 
 (<xref ref-type="bibr" rid="CIT0003">3</xref>).</p>
			<p>In this study we conjugated R-PE to antibodies by two various methods. Firstly, R-PE was attached to SMCC linker; and then, the antibody was attached to PE-SMCC (<xref ref-type="bibr" rid="CIT0003">3</xref>). Secondly, SH groups were added onto PE molecule, while the antibody was attached to SPDP linker. Then, the antibody-SPDP molecules were conjugated to R-PE (<xref ref-type="bibr" rid="CIT0004">4</xref>&#x2013;<xref ref-type="bibr" rid="CIT0006">6</xref>).</p>
		</sec>
		<sec id="S0002" sec-type="materials|methods">
			<title>Materials and Methods</title>
			<sec id="S20003">
				<title>Antibodies (Abs)</title>
				<p>For the purpose of conjugation, three different antibodies were prepared at Avicenna Research Institute, Tehran, Iran.</p>
				<p>These antibodies included sheep anti mouse immunoglobulins adsorbed against human immunoglobulins [Sh&#x3B1;M Ig (human Ig ads)], F(ab&#x0027;)2 fragment of sheep anti mouse immunoglobulins adsorbed against human immunoglobulins [Sh&#x3B1;M Ig F(ab&#x0027;)<sub>2</sub> (human Ig ads)], sheep anti human immunoglobulins adsorbed against mouse immunoglobulins [Sh&#x3B1;H (Mouse Ig Ads)].</p>
			</sec>
			<sec id="S20004">
				<title>Conjugation of R- PE to a reduced antibody by SMCC linker</title>
				<p>Sulfosuccinimidyl- 4-(<italic>N</italic>-maleimidomethyl) cyclohexane-1-carboxylate (Sulfo-SMCC) (Sigma- Aldrich, Wisconsin, USA) is a water-soluble heterobifunctional linker. It contains an amine-reactive <italic>N</italic>-hydroxysuccinimide (NHS ester) and a sulfhydryl-reactive maleimide group. First, 200 <italic>&#x00B5;g</italic> sulfo-SMCC was attached to 1 <italic>mg</italic> R-PE (2&#x2013;3 <italic>mg/ml</italic>) by the amine-reactive end for 1 <italic>hr</italic> with shaking in Phosphate Buffered Saline (PBS); then, the excess sulfo-SMCC was removed by dialysis in PBS at 4 &#x00B0;C overnight. The antibody was reduced by 20 <italic>mM</italic> Dithiothreitol (DTT) for 30 <italic>min</italic> without shaking; and then, DTT was rapidly removed by dialysis in PBS. The reduced antibody was immediately added to PE-SMCC where the sulfhydryl-reactive maleimide end in PE-SMCC was used to attach PE- SMCC to the reduced antibody. Then, the mixture was mixed for 6 <italic>hr</italic> at Room Temperature (RT). Finally, free SH groups on the antibody molecules were blocked by 40 <italic>mM</italic> N- Ethylmaleimide (NEM) for 30 <italic>min</italic> at RT (<xref ref-type="bibr" rid="CIT0003">3</xref>).</p>
			</sec>
			<sec id="S20005">
				<title>Conjugation of thiolated PE to the antibody by SPDP linker</title>
				<p>R-PE was thiolated by Traut&#x0027;s Reagent (2-Iminothiolane or 2-IT) (Sigma-Aldrich) for 1.5 <italic>hr</italic> at RT, while the antibody was attached to a heterobifunctional linker called SPDP (<italic>N</italic> -succinimidyl 3-(2-pyridyldithio)-propionate) (Uptima, Montiucon, Cedex, France) in PBS. Finally, thiolated R-PE was mixed with Ab-SPDP; resulting in Ab-SPDP-PE.</p>
			</sec>
			<sec id="S20006">
				<title>Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)</title>
				<p>To analyze conjugate quality, equal amounts of protein (10 <italic>&#x00B5;g</italic>) were run on 12.5% SDS-PAGE at 100 V for 2 <italic>hrs</italic> under discontinuous non-reducing condition using a Mini-Protean III electrophoresis apparatus (Bio-Rad, Hercules, CA).</p>
			</sec>
			<sec id="S20007">
				<title>Cell culture</title>
				<p>A mouse IgG-producing hybridoma cell line was grown in RPMI 1640 medium containing 10% (v/v) fetal calf serum (Invitrogen, California, USA) and 1% penicillin/ streptomycin (Sigma- Aldrich) at 37 &#x00B0;<italic>C</italic> in the presence of 5% Co2.</p>
			</sec>
			<sec id="S20008">
				<title>Immunocytochemistry</title>
				<p>Two different cell types were used in this experiment. A mouse IgG-producing hybrid-oma cell line and human B lymphocytes as part of Peripheral Blood Mononuclear Cells (PBMC) that were prepared from whole blood by Ficoll separation (<xref ref-type="bibr" rid="CIT0007">7</xref>). Forty thousand cells were added onto glass slides. After drying for 2 <italic>hr</italic> at RT, they were fixed by 2% formaldehyde. The fixed cells were washed and then blocked by 5% sheep serum. R-PE conjugated antibodies were added. Cells were washed with PBS and then observed directly under a fluorescent microscope (Olympus, Tokyo, Japan).</p>
			</sec>
		</sec>
		<sec id="S0009" sec-type="results">
			<title>Results</title>
			<sec id="S20010">
				<title>Electrophoretic pattern of both PE conjugated whole antibody and F(ab&#x0027;)2 fragments by SMCC linker</title>
				<p>
					<xref ref-type="fig" rid="F0001">Figures 1</xref> and <xref ref-type="fig" rid="F0002">2</xref> show electrophoretic mobility patterns of R-PE conjugated whole Sh&#x3B1;M Ig and F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig by SMCC linker in SDS-PAGE, respectively. Considering the fact that the conjugation of antibodies to R-PE may involve one or more R-PE subunits for each antibody molecule, the conjugation materials may show different electrophoretic mobility properties as reflected by a smear rather that a single sharp band in SDS-PAGE (<xref ref-type="bibr" rid="CIT0002">2</xref>).</p>
				<fig id="F0001">
					<label>Figure 1</label>
					<caption>
						<p>Electrophoretic pattern of R-PE conjugated Sh&#x3B1;M Ig by SMCC linker in non-reduced 12.5% SDS-PAGE: Lane 1 shows R-PE conjugated Sh&#x3B1;M Ig. Lane 2 shows unconjugated Sh&#x3B1;M Ig. Lane 3 shows R-PE alone</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g001.tif" alt-version="no"/>
				</fig>
				<fig id="F0002">
					<label>Figure 2</label>
					<caption>
						<p>Electrophoretic pattern of R-PE conjugated F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig by SMCC linker in non-reduced 12.5% SDS-PAGE. Lane 1 shows F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig (100 <italic>kDa</italic>). Lane 2 shows IgG molecule (150 <italic>kDa</italic>) as protein marker. Lane 3 shows R-PE alone. Lane 4 shows R-PE conjugated F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g002.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20011">
				<title>Electrophoretic pattern of both PE conjugated whole antibodies and F(ab&#x0027;)2 fragments by SPDP linker</title>
				<p>
					<xref ref-type="fig" rid="F0003">Figure 3</xref> shows electrophoretic mobility patterns of R-PE conjugated whole and F(ab&#x0027;)2 fragments of Sh&#x3B1;M Ig by SPDP in SDS-PAGE. Similar to SMCC linker method, the conjugation method using SPDP linker also resulted in smears because of different numbers of R-PE subunits bound per Ab molecule.</p>
				<fig id="F0003">
					<label>Figure 3</label>
					<caption>
						<p>Electrophoretic pattern of R-PE conjugated Sh&#x3B1;M Ig and F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig by SPDP linker in non-reduced 12.5% SDS-PAGE. Lane1 shows unconjugated F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig. Lane 2 shows unconjugated Sh&#x3B1;M Ig. Lane 3 shows R-PE alone. Lane 4 shows R-PE conjugated Sh&#x3B1;M Ig. Lane 5 shows R-PE conjugated F(ab&#x0027;)2 fragment of Sh&#x3B1;M Ig</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g002.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20012">
				<title>Immunocytochemistry analysis of antibodies conjugated by SMCC linker</title>
				<p>To analyze the specific binding of R-PE conjugated antibodies by SMCC linker method, conjugated whole Sh&#x3B1;M Ig and its F(ab&#x0027;)2 fragments were studied by ICC on a mouse IgG-producing hybridoma cell line. The R-PE conjugated Sh&#x3B1;H Ig as the control antibody was tested for its specific reactivity on human B lymphocyte in ICC assay as depicted in <xref ref-type="fig" rid="F0004">Figures 4A</xref> and <xref ref-type="fig" rid="F0004">B</xref>. Both Sh&#x3B1;M Ig &#x2013; R-PE and its R-PE conjugated F(ab&#x0027;)2 fragments could successfully bind to the cells (<xref ref-type="fig" rid="F0005">Figures 5A</xref> and <xref ref-type="fig" rid="F0005">B</xref>) while the negative control, R-PE conjugated Sh&#x3B1;H Ig (<xref ref-type="fig" rid="F0005">Figures 5C</xref>) did not bind to these cells.</p>
				<fig id="F0004">
					<label>Figure 4</label>
					<caption>
						<p>Immunocytochemistry analysis of R-PE conjugated Sh&#x3B1;H Ig on human B lymphocytes. A) Sh&#x3B1;H (Mouse Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100). B) Sh&#x3B1;M Ig (Human Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g004.tif" alt-version="no"/>
				</fig>
				<fig id="F0005">
					<label>Figure 5</label>
					<caption>
						<p>Immunocytochemistry analysis of Sh&#x3B1;M Ig &#x2013; R-PE and its R-PE conjugated F(ab&#x0027;)2 fragments by SMCC linker on a mouse IgG-producing hybridoma cell line. A) Sh&#x3B1;M Ig (Human Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100). B) F(ab&#x0027;)<sub>2</sub> fragment of Sh&#x3B1;M Ig (Human Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100). C) Sh&#x3B1;H (Mouse Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g005.tif" alt-version="no"/>
				</fig>
			</sec>
			<sec id="S20013">
				<title>Immunocytochemistry analysis of antibodies conjugated by SPDP linker</title>
				<p>Specific binding of whole R-PE conjugated Sh&#x3B1;M Ig and its F(ab&#x0027;)2 fragments by SPDP linker was tested by ICC on the mouse IgG-producing hybridoma cell line. As shown in <xref ref-type="fig" rid="F0006">Figure 6</xref> both antibody conjugates reacted to the cells (<xref ref-type="fig" rid="F0006">Figures 6A</xref> and <xref ref-type="fig" rid="F0006">B</xref>), while its negative control (Sh&#x3B1;H Ig-R-PE) was negative as shown in <xref ref-type="fig" rid="F0006">Figure 6C</xref>.</p>
				<fig id="F0006">
					<label>Figure 6</label>
					<caption>
						<p>Immunocytochemistry analysis of Sh&#x3B1;M Ig &#x2013; R-PE and its R-PE conjugated F(ab&#x0027;)2 fragments by SPDP linker on a mouse IgG-producing hybridoma cell line. A) Sh&#x3B1;M Ig (Human Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100). B) F(ab&#x0027;)<sub>2</sub> fragment of Sh&#x3B1;M Ig (Human Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100). C) Sh&#x3B1;H (Mouse Ig Ads)-PE (1 <italic>mg/ml</italic> dilution: 1/100)</p>
					</caption>
					<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-2-87-g006.tif" alt-version="no"/>
				</fig>
			</sec>
		</sec>
		<sec id="S0014" sec-type="discussion">
			<title>Discussion</title>
			<p>Though there are different methods to conjugate R-PE to antibodies, optimization of an efficient method is crucial. Conjugating R-PE molecules to antibodies without other adverse byproducts is our main goal in this conjugation. Considering the fact that R-PE &#x2013; R-PE and Ab &#x2013; Ab conjugates are not useful, a proper conjugation should attach R-PE to antibody specifically. The commonly used homobifunctional linkers, like glutaraldehyde, have some disadvantages. They result in high levels of adverse byproducts such as Ab &#x2013; Ab and R-PE &#x2013; R-PE conjugates; in addition, their chemical process is hard to control and may lead to unwanted polymerization of materials (<xref ref-type="bibr" rid="CIT0008">8</xref>). Hence, in order to conjugate R-PE to Abs, the most efficient method is using heterobifunctional linkers (<xref ref-type="bibr" rid="CIT0009">9</xref>). These linkers usually have two different end groups, an amine reactive group and a sulfhydryl reactive group, which provide a feasible tool to conjugate different molecules.</p>
			<p>Selecting an appropriate method to attach two different molecules depends on their structure or surface active groups. On account of the fact that the surface of R-PE molecule contains many amine groups (<xref ref-type="bibr" rid="CIT0010">10</xref>), and anti-bodies contain many intra-disulfide bonds (<xref ref-type="bibr" rid="CIT0011">11</xref>), these different properties could be used as a significant tool during an appropriate bioconjugation. Therefore, in our first conjugation method a heterobifunctional linker, sulfo-SMCC, was used to link the amine groups on R-PE molecule to the sulfhydryl groups in the reduced antibody molecules.</p>
			<p>However, this notion is challenged by some researchers who prefer to use the amine groups of antibody (<xref ref-type="bibr" rid="CIT0012">12</xref>). To examine this possibility in our system, we used the second conjugation method in which SPDP linker was used to conjugate thiolated R-PE to amine groups on the intact antibody molecules. The results of experiments showed that the antibodies retained their binding ability in both systems.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgment</title>
			<p>This work was supported by a grant from Avicenna Research Institute.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="CIT0001">
				<label>1</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Glazer</surname>
							<given-names>AN</given-names>
						</name>
					</person-group>
					<article-title>Phycobilisomes: structure and dynamics</article-title>
					<source>Annu Rev Microbiol</source>
					<year>1982</year>
					<volume>36</volume>
					<issue>1</issue>
					<fpage>173</fpage>
					<lpage>198</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0002">
				<label>2</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Chang</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Liang</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<article-title>Crystal structure of R-phycocyanin and possible energy transfer pathways in the phycobilisome</article-title>
					<source>Biophys J</source>
					<year>2001</year>
					<volume>81</volume>
					<issue>2</issue>
					<fpage>1171</fpage>
					<lpage>1179</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0003">
				<label>3</label>
				<nlm-citation citation-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Hardy</surname>
							<given-names>RR</given-names>
						</name>
					</person-group>
					<article-title>Purification and coupling of fluorescent proteins for use in flow cytometry</article-title>
					<source>Handbook of experimental immunology</source>
					<year>1986</year>
					<edition>4th ed</edition>
					<publisher-loc>Oxford</publisher-loc>
					<publisher-name>Black-well Scientific</publisher-name>
				</nlm-citation>
			</ref>
			<ref id="CIT0004">
				<label>4</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Chambers</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>Simon</surname>
							<given-names>SI</given-names>
						</name>
						<name>
							<surname>Berger</surname>
							<given-names>EM</given-names>
						</name>
						<name>
							<surname>Sklar</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Arfors</surname>
							<given-names>KE</given-names>
						</name>
					</person-group>
					<article-title>Endocytosis of beta 2 integrins by stimulated human neutrophils analyzed by flow cytometry</article-title>
					<source>J Leukoc Biol</source>
					<year>1993</year>
					<volume>53</volume>
					<issue>4</issue>
					<fpage>462</fpage>
					<lpage>469</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0005">
				<label>5</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kronick</surname>
							<given-names>MN</given-names>
						</name>
						<name>
							<surname>Grossman</surname>
							<given-names>PD</given-names>
						</name>
					</person-group>
					<article-title>Immunoassay techniques with fluorescent phycobiliprotein conjugates</article-title>
					<source>Clin Chem</source>
					<year>1983</year>
					<volume>29</volume>
					<issue>9</issue>
					<fpage>1582</fpage>
					<lpage>1586</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0006">
				<label>6</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Oi</surname>
							<given-names>VT</given-names>
						</name>
						<name>
							<surname>Glazer</surname>
							<given-names>AN</given-names>
						</name>
						<name>
							<surname>Stryer</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Fluorescent phycobili-protein conjugates for analyses of cells and molecules</article-title>
					<source>J Cell Biol</source>
					<year>1982</year>
					<volume>93</volume>
					<issue>3</issue>
					<fpage>981</fpage>
					<lpage>986</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0007">
				<label>7</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ferrante</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Thong</surname>
							<given-names>YH</given-names>
						</name>
					</person-group>
					<article-title>Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the hypaque-ficoll method</article-title>
					<source>J Immunol Methods</source>
					<year>1980</year>
					<volume>36</volume>
					<issue>2</issue>
					<fpage>109</fpage>
					<lpage>117</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0008">
				<label>8</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Migneault</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Dartiguenave</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Bertrand</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Wald-ron</surname>
							<given-names>KC</given-names>
						</name>
					</person-group>
					<article-title>Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking</article-title>
					<source>BioTechniques</source>
					<year>2004</year>
					<volume>37</volume>
					<issue>5</issue>
					<fpage>790</fpage>
					<lpage>802</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0009">
				<label>9</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mattson</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Conklin</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Desai</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Nielander</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Savage</surname>
							<given-names>MD</given-names>
						</name>
						<name>
							<surname>Morgensen</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>A practical approach to crosslinking</article-title>
					<source>Mol Biol Rep</source>
					<year>1993</year>
					<volume>17</volume>
					<issue>3</issue>
					<fpage>167</fpage>
					<lpage>183</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0010">
				<label>10</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Liang</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<article-title>Structure and function of chromophores in R-phycoerythrin at 1.9 A resolution</article-title>
					<source>Proteins</source>
					<year>1999</year>
					<volume>34</volume>
					<issue>2</issue>
					<fpage>224</fpage>
					<lpage>231</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0011">
				<label>11</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wang</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Singh</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Zeng</surname>
							<given-names>DL</given-names>
						</name>
						<name>
							<surname>King</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Nema</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Antibody structure, instability, and formulation</article-title>
					<source>J Pharm Sci</source>
					<year>2006</year>
					<volume>96</volume>
					<issue>1</issue>
					<fpage>1</fpage>
					<lpage>26</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0012">
				<label>12</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Barbet</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Machy</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Leserman</surname>
							<given-names>LD</given-names>
						</name>
					</person-group>
					<article-title>Monoclonal antibody covalently coupled to liposomes: specific targeting to cells</article-title>
					<source>J Supramol Struct Cell Biochem</source>
					<year>2004</year>
					<volume>16</volume>
					<issue>3</issue>
					<fpage>243</fpage>
					<lpage>258</lpage>
				</nlm-citation>
			</ref>
		</ref-list>
	</back>
</article>
